These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9000260

  • 1. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ, Lindström E, Håkanson R.
    Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
    [Abstract] [Full Text] [Related]

  • 4. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S, Moizo L, Laigneau JP, Alchepo B, Lewin MJ, Bado A.
    Fundam Clin Pharmacol; 1998 Jul; 12(3):256-62. PubMed ID: 9646057
    [Abstract] [Full Text] [Related]

  • 5. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
    Ding XQ, Kitano M, Håkanson R.
    Pharmacol Toxicol; 1998 Apr; 82(4):177-82. PubMed ID: 9584331
    [Abstract] [Full Text] [Related]

  • 6. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ, Lindström E, Håkanson R.
    Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation.
    Nishida A, Uchida-Kobayashi A, Takemoto Y, Akuzawa S, Miyata K.
    Jpn J Pharmacol; 1996 Jul; 71(3):223-30. PubMed ID: 8854204
    [Abstract] [Full Text] [Related]

  • 13. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [Abstract] [Full Text] [Related]

  • 14. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
    Nishida A, Yuki H, Tsutsumi R, Miyata K, Kamato T, Ito H, Yamano M, Honda K.
    Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
    [Abstract] [Full Text] [Related]

  • 15. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Takemoto Y, Yuki H, Nishida A, Ito H, Kobayashi-Uchida A, Takinami Y, Akuzawa S, Ohta M, Satoh M, Semple G, Miyata K.
    Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884
    [Abstract] [Full Text] [Related]

  • 16. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 17. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.
    Chem Pharm Bull (Tokyo); 1996 Jul 12; 44(7):1412-4. PubMed ID: 8706146
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ, Lindström E, Håkanson R.
    Pharmacol Toxicol; 1997 Nov 12; 81(5):232-7. PubMed ID: 9396089
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
    Lindström E, Björkqvist M, Håkanson R.
    Br J Pharmacol; 1999 May 12; 127(2):530-6. PubMed ID: 10385255
    [Abstract] [Full Text] [Related]

  • 20. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C, Lazzeri G, Colucci R, Carignani D, Tognetti M, Baschiera F, Del Tacca M.
    Eur J Pharmacol; 1999 May 28; 373(1):71-84. PubMed ID: 10408253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.